Based on recent data, GSK plc (GSK) shows an Average True Range (ATR) of 1.15 and an Enterprise Value of 81.59B. Its average trading volume over the past 3 months is 3.89M, indicating liquidity. These fundamental metrics provide insight into GSK's underlying financial health and market activity.
| ATR | 1.15 |
| Enterprise Value | 81.59B |
| Avg Vol (3 Months) | 3.89M |
| Avg Vol (10 Days) | 3.8M |
GSK plc (GSK) technical indicators as of July 5, 2026: the SMA 20 is 0.38%, SMA 50 at 10.09%, and SMA 200 at 30.88%. The RSI 14 value is 57.8, suggesting its current momentum. These technical analysis signals help assess GSK's price trends and potential future movements.
| SMA 20 | 0.38% |
| SMA 50 | 10.09% |
| SMA 200 | 30.88% |
| RSI 14 | 57.8 |
GSK plc (GSK) stock performance overview as of July 5, 2026: The 52-week high is $61.7 (currently -5.88% below), and the 52-week low is $35.45 (currently 79.32% above). Over the past year, GSK's performance is 42.49%, compared to the S&P 500's 6.06% change.
| 52-Week High | 61.7 |
| 52-Week High Chg | -5.88% |
| 52-Week Low | 35.45 |
| 52-Week Low Chg | +79.32% |
| S&P 500 52-Week Chg | 6.06% |
According to market data, GSK plc (GSK) stock's recent performance metrics show that over the last month, GSK is -2.18%, with a Year-to-Date (YTD) performance of -2.83%. Over the past year, the stock has seen a 42.49% change. These figures summarize GSK's price movements across various periods, reflecting its historical returns.
| Period | 1 Week | 1 Month | Quarter | Half Year | 1 Year | YTD |
|---|---|---|---|---|---|---|
| High | 53.84 | 53.84 | 59.57 | 61.7 | 61.7 | 61.7 |
| Low | 51.08 | 49.39 | 49.18 | 47.62 | 35.45 | 47.62 |
| Performance | -5.44% | -2.18% | +8.52% | +31.63% | +42.49% | -2.83% |
According to current financial data, GSK stock's P/E (TTM) ratio is 11.75, which compares to the S&P 500's P/E of 32.59. The sector median P/E is -1.22. Key valuation ratios for GSK, including P/S (2.46), P/B (3.43), and P/FCF (12.91), offer insights into how the company is valued relative to its earnings, sales, book value, and free cash flow.
| Valuation | GSK | Sector Median | Industry Avg | S&P 500 |
|---|---|---|---|---|
| P/E (TTM) | 11.75 | -1.22 | 68.03 | 32.59 |
| P/S (TTM) | 2.46 | 3.68 | 4.83 | 5.98 |
| P/B (TTM) | 3.43 | 0.92 | 6.79 | 5.19 |
| P/FCF (TTM) | 12.91 | -11.82 | 16.78 | 29.39 |
© 2026 Stocks Telegraph All rights reserved.
Most stock quote data provided by Financial Modeling Prep